The Effects of Study Products Containing Varying Quantities of Docosahexaenoic Acid (DHA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01174134
Recruitment Status : Completed
First Posted : August 3, 2010
Last Update Posted : September 2, 2011
Information provided by:
Mead Johnson Nutrition

Brief Summary:
The clinical trial will provide a milk-based drink with constant amounts of nutrients but differing amount of Docosahexaenoic Acid (DHA).

Condition or disease Intervention/treatment Phase
Levels of DHA in the Blood Other: Nutritional beverage Not Applicable

Study Type : Interventional  (Clinical Trial)
Study Start Date : July 2006
Actual Primary Completion Date : May 2007

Arm Intervention/treatment
Placebo Comparator: Milk-based beverage w/out DHA Other: Nutritional beverage
Experimental: Milk-based beverage with DHA Other: Nutritional beverage
Experimental: Milk-based beverage containing DHA at a higher level Other: Nutritional beverage

Primary Outcome Measures :
  1. Blood lipid levels of Docosahexaenoic Acid (DHA) at enrollment and after two months, assessment of usual DHA intake, and product acceptability and use

Secondary Outcome Measures :
  1. Growth
  2. Determination of nutrient status, including iron and vitamin D status
  3. Adverse Events

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Months to 36 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Participant is 18 to 36 months of age
  • Participant's current weight and height within the 10th to 90th percentiles
  • Parent/caregiver reports that participant consumes milk or a milk-based beverage on a daily basis
  • Participant lives at home with parent(s) or other family member(s)
  • Signed informed consent and authorization obtained to use and or disclose Protected Health Information (PHI)

Exclusion Criteria:

  • Participant who is receiving any breast milk at time of randomization
  • Participant with an active infection.
  • Participant with a history of underlying disease, chronic disease, or congenital malformation which in the opinion of the Investigator is likely to interfere with the evaluation of the participant.
  • Known or suspected intolerance to cow's milk protein
  • Participant diagnosed with diabetes
  • Participant is from a multiple birth and the sibling(s) are still living
  • Participant with a sibling that has participated in this study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01174134

United States, Kansas
University of Kansas
Kansas City, Kansas, United States, 66160
Sponsors and Collaborators
Mead Johnson Nutrition
Principal Investigator: Susan Carlson, Ph.D. University of Kansas

Responsible Party: Carol Berseth, M.D., Mead Johnson Nutrition Identifier: NCT01174134     History of Changes
Other Study ID Numbers: 3375-1
First Posted: August 3, 2010    Key Record Dates
Last Update Posted: September 2, 2011
Last Verified: August 2011